Net Income (Loss) Attributable to Parent in USD of Skye Bioscience, Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Skye Bioscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2012 to Q3 2025.
  • Skye Bioscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$12.8M, a 227% decline year-over-year.
  • Skye Bioscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$51.2M, a 141% decline year-over-year.
  • Skye Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$26.6M, a 29.4% increase from 2023.
  • Skye Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.6M, a 93.2% decline from 2022.
  • Skye Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.5M, a 129% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Skye Bioscience, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$51.2M -$12.8M -$8.86M -227% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$42.4M -$17.6M -$9.72M -123% 01 Apr 2025 30 Jun 2025 10-Q 10 Nov 2025
Q1 2025 -$32.7M -$11.1M -$6.08M -121% 01 Jan 2025 31 Mar 2025 10-Q 10 Nov 2025
Q4 2024 -$26.6M -$9.75M -$5.33M -121% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$21.2M -$3.9M +$21M +84.4% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$42.3M -$7.9M -$4.79M -154% 01 Apr 2024 30 Jun 2024 10-Q 10 Nov 2025
Q1 2024 -$37.5M -$5.02M +$148K +2.86% 01 Jan 2024 31 Mar 2024 10-Q 10 Nov 2025
Q4 2023 -$37.6M -$4.42M +$5.47M +55.3% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$43.1M -$24.9M -$21.8M -698% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$21.3M -$3.11M +$308K +9% 01 Apr 2023 30 Jun 2023 10-Q 07 Nov 2024
Q1 2023 -$21.6M -$5.17M -$2.12M -69.8% 01 Jan 2023 31 Mar 2023 10-Q 07 Nov 2024
Q4 2022 -$19.5M -$9.89M -$7.38M -294% 01 Oct 2022 31 Dec 2022 10-K 22 Mar 2024
Q3 2022 -$12.1M -$3.13M -$1.3M -71.4% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$10.8M -$3.42M -$1.4M -68.9% 01 Apr 2022 30 Jun 2022 10-Q 14 Nov 2023
Q1 2022 -$9.41M -$3.04M -$883K -40.9% 01 Jan 2022 31 Mar 2022 10-Q 14 Nov 2023
Q4 2021 -$8.52M -$2.51M -$1.01M -67.3% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$7.51M -$1.82M -$528K -40.7% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$6.98M -$2.02M -$604K -42.5% 01 Apr 2021 30 Jun 2021 10-Q 14 Nov 2022
Q1 2021 -$6.38M -$2.16M +$181K +7.74% 01 Jan 2021 31 Mar 2021 10-Q 14 Nov 2022
Q4 2020 -$6.56M -$1.5M -$6.35M -131% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 -$207K -$1.3M +$3.63M +73.7% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$3.84M -$1.42M -$17.3M -109% 01 Apr 2020 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 $13.5M -$2.34M +$12.4M +84.2% 01 Jan 2020 31 Mar 2020 10-Q 10 Nov 2021
Q4 2019 $1.05M $4.85M +$11.1M 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 -$10M -$4.93M -$2.83M -135% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$7.19M $15.9M +$18.6M 01 Apr 2019 30 Jun 2019 10-Q 06 Nov 2020
Q1 2019 -$25.8M -$14.8M -$6.56M -79.9% 01 Jan 2019 31 Mar 2019 10-Q 06 Nov 2020
Q4 2018 -$19.2M -$6.22M -$5.59M -890% 01 Oct 2018 31 Dec 2018 10-K 23 Mar 2020
Q3 2018 -$13.6M -$2.1M -$1.62M -337% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$12M -$2.66M -$1.96M -279% 01 Apr 2018 30 Jun 2018 10-Q 14 Nov 2019
Q1 2018 -$10M -$8.21M -$6.93M -540% 01 Jan 2018 31 Mar 2018 10-Q 14 Nov 2019
Q4 2017 -$3.09M -$628K +$492K +43.9% 01 Oct 2017 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 -$3.59M -$480K +$465K +49.2% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$4.05M -$703K -$1.28M -223% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$2.78M -$1.28M +$402K +23.9% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$3.18M -$1.12M -$429K -62.1% 01 Oct 2016 31 Dec 2016 10-K 19 Mar 2018
Q3 2016 -$2.75M -$945K +$238K +20.1% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$2.99M $573K +$2.63M 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$5.62M -$1.69M -$775K -85.2% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$4.84M -$691K +$1.01M +59.4% 01 Oct 2015 31 Dec 2015 10-K 10 Mar 2017
Q3 2015 -$5.85M -$1.18M -$324K -37.8% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$5.53M -$2.06M -$1.91M -1339% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016
Q1 2015 -$3.61M -$910K -$880K -2924% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$2.73M -$1.7M -$1.71M 01 Oct 2014 31 Dec 2014 10-K 21 Mar 2016
Q3 2014 -$1.03M -$859K -$828K -2752% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$200K -$143K -$142K 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$57.3K -$30.1K -$2.1M -101% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 $2.04M $3.62K* +$3.46K 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2014
Q3 2013 $2.04M -$30.1K 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$712* -$767 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014
Q1 2013 $2.07M +$2.07M 31 Jan 2013 30 Apr 2013 10-Q 05 Jun 2014
Q4 2012 $160* 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014
Q2 2012 $55.00* 01 May 2012 31 Jul 2012 10-Q 16 Sep 2013
Q1 2012 -$381* 31 Jan 2012 30 Apr 2012 10-Q 27 Jun 2013

Skye Bioscience, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$26.6M +$11.1M +29.4% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$37.6M -$18.2M -93.2% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$19.5M -$11M -129% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024
2021 -$8.52M -$1.96M -29.9% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$6.56M -$7.61M -724% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 $1.05M +$20.2M 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 -$19.2M -$16.1M -520% 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020
2017 -$3.09M +$83.8K +2.64% 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019
2016 -$3.18M +$1.66M +34.4% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018
2015 -$4.84M -$2.11M -77.1% 01 Jan 2015 31 Dec 2015 10-K 10 Mar 2017
2014 -$2.73M -$2.61M -2171% 01 Jan 2014 31 Dec 2014 10-K 21 Mar 2016
2013 -$120K -$125K -2770% 01 Jan 2013 31 Dec 2013 10-K 27 Mar 2015
2012 $4.51K 01 Nov 2011 31 Oct 2012 10-K 27 Jan 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.